awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38160838-91851372-686B-494C-9ED1-B589EFF5B777
Q38160838-91851372-686B-494C-9ED1-B589EFF5B777
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38160838-91851372-686B-494C-9ED1-B589EFF5B777
Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety.
P2860
Q38160838-91851372-686B-494C-9ED1-B589EFF5B777
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38160838-91851372-686B-494C-9ED1-B589EFF5B777
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7fe18a66f99ae2ed2b211762aee33bf3e540f1ee
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.